ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 119 filers reported holding ALDEYRA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.46 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,247,624 | -58.4% | 935,273 | -47.7% | 0.07% | -63.5% |
Q2 2023 | $15,005,297 | -3.4% | 1,788,474 | +14.3% | 0.20% | -7.0% |
Q1 2023 | $15,540,728 | +43.3% | 1,565,028 | +0.4% | 0.22% | +27.2% |
Q4 2022 | $10,845,921 | -15.5% | 1,558,322 | -67.6% | 0.17% | +16.6% |
Q3 2022 | $12,840,828 | +69.3% | 4,804,478 | +152.7% | 0.14% | -3.3% |
Q2 2022 | $7,586,000 | -19.0% | 1,901,191 | -9.7% | 0.15% | +33.9% |
Q1 2022 | $9,361,000 | +71.2% | 2,105,907 | +54.1% | 0.11% | +187.2% |
Q4 2021 | $5,467,000 | -34.3% | 1,366,701 | +44.1% | 0.04% | -45.8% |
Q3 2021 | $8,325,000 | +39.2% | 948,207 | +79.6% | 0.07% | +33.3% |
Q2 2021 | $5,980,000 | +20.8% | 527,831 | +26.7% | 0.05% | -3.6% |
Q1 2021 | $4,951,000 | +266.7% | 416,717 | +111.8% | 0.06% | +366.7% |
Q4 2020 | $1,350,000 | -38.5% | 196,754 | -33.6% | 0.01% | -72.7% |
Q3 2020 | $2,195,000 | +2285.9% | 296,180 | +1246.3% | 0.04% | +1366.7% |
Q2 2020 | $92,000 | -96.3% | 22,000 | -92.0% | 0.00% | -96.9% |
Q1 2019 | $2,485,000 | +98.5% | 275,205 | +82.5% | 0.10% | +7.8% |
Q4 2018 | $1,252,000 | – | 150,805 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 908,488 | $6,232,000 | 2.88% |
Knoll Capital Management, LLC | 569,405 | $3,906,000 | 2.66% |
Mesirow Financial Investment Management, Inc. | 64,698 | $443,828,000 | 1.40% |
Ghost Tree Capital, LLC | 650,000 | $4,459,000 | 0.99% |
Johnson & Johnson Innovation - JJDC, Inc. | 594,834 | $4,081,000 | 0.53% |
Perceptive Advisors | 6,285,458 | $43,118,000 | 0.46% |
Affinity Asset Advisors, LLC | 100,000 | $686,000 | 0.36% |
ACUTA CAPITAL PARTNERS, LLC | 192,500 | $1,321,000 | 0.36% |
Avidity Partners Management LP | 1,435,000 | $9,844,000 | 0.32% |
APOGEM CAPITAL LLC | 55,821 | $383,000 | 0.26% |